AskTheDate.com
Back to calendar

Prelude Therapeutics Incorporated (PRLD) Earnings

PRLD reports earnings on Thursday, November 5, 2026

earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $0.11
Actual EPS: $-0.14
EPS surprise: 28.81%
Company overview
Market Cap$446.9M
PriceUSD 5.60
EPS (TTM)-0.79
52-week high6.83
52-week low0.98
SectorHealth Technology
IndustryBiotechnology
Employees79
Buy me a coffee